CIBC Bancorp USA
ABBV icon

CIBC Bancorp USA’s AbbVie ABBV Stock Holding History

CIBC Bancorp USA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$400M Sell
1,529,463
-330,567
-18% -$84.7M 0.5% 35
2026
Q2 		$468M Buy
1,860,030
+133,102
+8% +$28.6M 0.57% 32
2026
Q1 		$376M Buy
+1,726,928
New +$383M 0.5% 41
2025
Q3 		$56.4M Buy
+243,718
New +$49.6M 0.31% 53

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

CIBC Bancorp USA's ABBV Position: Q3 2026 in Review

CIBC Bancorp USA reduced its AbbVie (ABBV) stake by 18% in Q3 2026, selling an estimated $84.7M and leaving 1,529,463 shares worth $400M. The position accounts for 0.5% of the portfolio, ranked #35.

CIBC Bancorp USA first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $468M in Q2 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • CIBC Bancorp USA held 1,529,463 shares of AbbVie worth $400M as of Q3 2026.
  • CIBC Bancorp USA sold 330,567 AbbVie shares in Q3 2026, an estimated $84.7M.
  • AbbVie made up 0.5% of CIBC Bancorp USA's portfolio in Q3 2026, its #35 holding.
  • CIBC Bancorp USA first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's AbbVie position peaked at $468M in Q2 2026.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.